Filters: Keyword is Survival Analysis [Clear All Filters]
"Clinical importance of HIV and depressive symptoms among veterans with HIV infection." Journal of general internal medicine 17, no. 7 (2002): 512-20. Abstract
"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies." Lancet 360, no. 9327 (2002): 119-29. Abstract
"Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era." Medical decision making : an international journal of the Society for Medical Decision Making 23, no. 1 (2003): 9-20. Abstract
"An evaluation of the dose-response relationship in naturalistic treatment settings using survival analysis." Mental health services research 5, no. 1 (2003): 1-12. Abstract
"Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data." American journal of public health 93, no. 10 (2003): 1728-33. Abstract
"Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy." Statistics in medicine 23, no. 15 (2004): 2375-98. Abstract
"Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection." Hepatology (Baltimore, Md.) 40, no. 1 (2004): 115-9. Abstract
"Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease." Journal of acquired immune deficiency syndromes (1999) 39, no. 1 (2005): 69-77. Abstract
"Buprenorphine and HIV primary care: new opportunities for integrated treatment." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S169-72. Abstract
"The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S178-83. Abstract
"The survival benefits of AIDS treatment in the United States." The Journal of infectious diseases 194, no. 1 (2006): 11-9. Abstract
"A framework for tailoring clinical guidelines to comorbidity at the point of care." Archives of internal medicine 167, no. 21 (2007): 2361-5. Abstract
"Effect of early versus deferred antiretroviral therapy for HIV on survival." The New England journal of medicine 360, no. 18 (2009): 1815-26. Abstract
"Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans." AIDS education and prevention : official publication of the International Society for AIDS Education 21, no. 3 Suppl (2009): 40-53. Abstract
"Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 49, no. 10 (2009): 1570-8. Abstract
"Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 49, no. 10 (2009): 1582-90. Abstract
"Rural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection." Medical care 48, no. 12 (2010): 1064-70. Abstract
"Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers." HIV medicine 11, no. 2 (2010): 143-51. Abstract
"WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers." PloS one 6, no. 6 (2011): e20224. Abstract
"The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C." Circulation. Cardiovascular quality and outcomes 4, no. 4 (2011): 425-32. Abstract
"Critical illness in HIV-infected patients in the era of combination antiretroviral therapy." Proceedings of the American Thoracic Society 8, no. 3 (2011): 301-7. Abstract
"Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?" Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 54, no. 7 (2012): 984-94. Abstract
"Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 16, no. 1 (2012): 90-7. Abstract
"A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa." Journal of acquired immune deficiency syndromes (1999) 60, no. 2 (2012): 150-7. Abstract
"Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration." Journal of acquired immune deficiency syndromes (1999) 69, no. 3 (2015): 348-54. Abstract
